{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:02:50Z","timestamp":1790240570890,"version":"4.1.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:00:00Z","timestamp":1565827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Delafloxacin is an option for infections due to methicillin-resistant Staphylococcus aureus. In 2017, 22% of isolates from 7 hospitals in Brooklyn, New York, were nonsusceptible to delafloxacin. Isolates belonging to ST105, a strain associated with healthcare-related infections, predominated. Resistance was also found in ST8, a strain (USA300) associated with community-associated infections.<\/jats:p>","DOI":"10.1093\/cid\/ciz787","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T19:14:50Z","timestamp":1565378090000},"page":"1758-1760","source":"Crossref","is-referenced-by-count":34,"title":["Emergence of Delafloxacin-Resistant Staphylococcus aureus in Brooklyn, New York"],"prefix":"10.1093","volume":"70","author":[{"given":"Alejandro","family":"Iregui","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, State University of New York\u2013Downstate Medical Center, Brooklyn"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeb","family":"Khan","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, State University of New York\u2013Downstate Medical Center, Brooklyn"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saquib","family":"Malik","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, State University of New York\u2013Downstate Medical Center, Brooklyn"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Landman","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, State University of New York\u2013Downstate Medical Center, Brooklyn"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Quale","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, State University of New York\u2013Downstate Medical Center, Brooklyn"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,15]]},"reference":[{"key":"2020041000555522300_CIT0001","doi-asserted-by":"crossref","first-page":"e0143276","DOI":"10.1371\/journal.pone.0143276","article-title":"Rising United States hospital admissions for acute bacterial skin and skin structure infections: recent trends and economic impact","volume":"10","author":"Kaye","year":"2015","journal-title":"PLoS One"},{"key":"2020041000555522300_CIT0002","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/mdr.2012.0056","article-title":"Molecular characterization of Staphylococcus aureus in the United States 2004\u20132008 reveals the rapid expansion of USA300 among inpatients and outpatients","volume":"18","author":"O\u2019Hara","year":"2012","journal-title":"Microbial Drug Resist"},{"key":"2020041000555522300_CIT0003","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/cid\/ciy600","article-title":"Delafloxacin: a new anti-methicillin-resistant Staphylococcus aureus fluoroquinolone","volume":"68","author":"Saravolatz","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020041000555522300_CIT0004","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1128\/AAC.48.7.2771-2777.2004","article-title":"In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against gram-positive and gram-negative organisms","volume":"48","author":"Almer","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041000555522300_CIT0005","doi-asserted-by":"crossref","first-page":"e02609","DOI":"10.1128\/AAC.02609-16","article-title":"In vitro activity of delafloxacin against contemporary bacterial pathogens from the United States and Europe, 2014","volume":"61","author":"Pfaller","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041000555522300_CIT0006","doi-asserted-by":"crossref","first-page":"e00772","DOI":"10.1128\/AAC.00772-17","article-title":"In vitro activity of delafloxacin and microbiological response against fluoroquinolone-susceptible and nonsusceptible Staphylococcus aureus isolates from two phase 3 studies of acute bacterial skin and skin structure infections","volume":"61","author":"McCurdy","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041000555522300_CIT0007","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dkh242","article-title":"ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model","volume":"54","author":"Firsov","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"2020041000555522300_CIT0008","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1128\/AAC.47.10.3260-3269.2003","article-title":"In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone","volume":"47","author":"Nilius","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041000555522300_CIT0009","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/jac\/dks307","article-title":"Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization","volume":"67","author":"Remy","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2020041000555522300_CIT0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/cid\/ciy165","article-title":"A comparison of the efficacy and safety of intravenous followed by oral delafloxacin with vancomycin plus aztreonam for the treatment of acute bacterial skin and skin structure infections: a phase 3, multinational, double-blind, randomized study","volume":"67","author":"O\u2019Riordan","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020041000555522300_CIT0011","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2017","edition":"27th ed."},{"key":"2020041000555522300_CIT0012","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/JCM.38.3.1008-1015.2000","article-title":"Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus","volume":"38","author":"Enright","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2020041000555522300_CIT0013","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1472-765X.2011.03010.x","article-title":"Synergistic activity of 1-(1-naphthylmethyl)-piperazine with ciprofloxacin against clinically resistant Staphylococcus aureus, as determined by different methods","volume":"52","author":"Li","year":"2011","journal-title":"Lett Appl Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz787\/30049132\/ciz787.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/8\/1758\/33031838\/ciz787.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/8\/1758\/33031838\/ciz787.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T05:10:36Z","timestamp":1586495436000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/70\/8\/1758\/5550172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,15]]},"references-count":13,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,15]]},"published-print":{"date-parts":[[2020,4,10]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz787","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4,15]]},"published":{"date-parts":[[2019,8,15]]}}}